Conferences Celerion is attending in 2026–2027

LinkedIn celerion.com

Celerion is listed at 3 conferences on Tnuki's calendar in 2026–2027: AAPS 2026 PharmSci 360 (on the program), EBF 2026 (Sponsor) and SCOPE 2027 (exhibiting). Celerion is a clinical research organization providing early-phase clinical trials, bioanalytical services, and drug development support. As of Oct 17, 2026.

Show
ConferenceDetailsInvolvementTnuki guide
AAPS 2026 PharmSci 360Pharmaceutical development scientistsOfficial site
New Orleans, LA ~4k attendees On the programNo booth or sponsorship in the organizer’s published lists
Program 3 posters, 1 symposium
Attending
  • Principal Scientist
  • Validation Team Leader-LBA
  • Vice President
Attendee mix: Mostly pharma; formulation, bioanalytical and biologics scientists, CDMOs and drug-development suppliers
Open the guide Search and filter attendees
19th EBF Open SymposiumEuropean pharma & CRO bioanalystsOfficial site
Barcelona, Spain ~800 attendees ◇SponsorAs published by European Bioanalysis Forum
Program 2 talks
Attending
  • speaker
Attendee mix: Almost entirely industry; regulated bioanalysis scientists and leads at pharma, biotech and CROs
Open the guide Search and filter attendees
SCOPE Summit 2027Clinical operations & trial technology leadersOfficial site
Orlando, FL ~5k attendees ExhibitorAs published by SCOPE Summit
Booth 1037
Attendee mix: Almost entirely industry; clinical operations executives at pharma, biotech and CROs
Open the guide Search and filter attendees

We hold published exhibitor, sponsor, program or attendee lists for 54 of the 156 conferences on our calendar, so this page shows Celerion’s involvement at those 54 only — it is not a complete record of where they go. Organizers typically publish a list around six months before the event, so coverage grows over time.

Instantly find decision makers at Celerion

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

See what Tnuki can do

Explore our deep integration of account and market intelligence, in one easy-to-use chat.

Or talk to a human →